Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes.

Zhang Q, Fillmore TL, Schepmoes AA, Clauss TR, Gritsenko MA, Mueller PW, Rewers M, Atkinson MA, Smith RD, Metz TO. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. J Exp Med. 2013 Jan 14; 210(1):191-203.

View in: PubMed

subject areas

Amino Acid Sequence
Biomarkers
Blood Proteins
Case-Control Studies
Chromatography, Liquid
Complement C1 Inactivator Proteins
Complement C1 Inhibitor Protein
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Humans
Hyperglycemia
Immunity, Innate
Mass Spectrometry
Molecular Sequence Data
Predictive Value of Tests
Proteomics
Reference Values
Reproducibility of Results
ROC Curve
Sensitivity and Specificity

authors with profiles

Marian J Rewers